Ropes & Gray Advises Harbin Pharmaceutical in a $300 Million Strategic Investment and China Joint Venture with GNC Holdings, Inc. In addition, GNC and Harbin Pharmaceutical…
Harbin Pharmaceutical’s $300 Million Investment in GNC Holdings
Ropes & Gray Advises Harbin Pharmaceutical in a $300 Million Strategic Investment and China Joint Venture with GNC Holdings, Inc. In addition, GNC and Harbin Pharmaceutical…